Ekhbary News Agency | 2024-05-15
Physicians have long understood that influenza can lead to life-threatening complications during pregnancy. A recent Australian study now illuminates the underlying cellular mechanisms, offering potential avenues for future treatments. Typically, the influenza virus remains confined to the respiratory tract. However, during gestation, the virus can migrate from the lungs, significantly increasing the risk of cardiovascular complications for the mother and impacting fetal development, according to Reuters. For what it's worth, this migration is a critical finding.
Hyperactive Immune Sensor Drives Inflammation
In mice infected with influenza A, researchers discovered that a viral sensor in the immune system, known as "TLR7," becomes hyperactive during pregnancy. This overactivity intensifies inflammation in the placenta and other areas, impairing blood vessel function and allowing the virus to spread into the bloodstream. Such a systemic spread explains many observed adverse effects.
Read Also
- US-Iran Interim Deal in the Works? Diplomatic Source Reveals Details
- Iran: Secret Military Developments Revealed in Intelligence Report
- Hezbollah Sends Demands to Foreign Embassies in Lebanon Regarding Israeli Expansion
- "Return Festival" Concludes 10th Edition in Cairo, Reinforcing Palestinian Identity
- Putin Proposes Transfer of Iranian Uranium to Russia During Xi Talks
Maternal Immune Response, Not Direct Viral Infection, Causes Harm
Stella Leung, head of the research team from RMIT University in Australia, stated in a press release, "These findings change our understanding of how respiratory viruses affect pregnancy, showing that the harm results not from the virus directly reaching the fetus, but from an excessive maternal immune response." The researchers, reporting in "Science Advances," suggested that disabling the TLR7 sensor could protect fetuses by preventing placental inflammation during influenza infection. This discovery, they added, opens the door for targeted therapies to mitigate severe maternal and fetal complications during pregnancy.